Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Intravenous versus subcutaneous immunoglobulin - Authors' reply

Ivo N van Schaik¹, Orell Mielke²,

¹Department of Neurology, Academic Medical Centre, University of Amsterdam, 1105 AZ Amsterdam, Netherlands.

The Lancet. Neurology

|April 17, 2018

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Intravenous methylprednisolone as add-on induction therapy for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial.

Journal of neurology, neurosurgery, and psychiatry·2026

Same author

Automatically quantified follow-up imaging biomarkers predict clinical outcomes after acute ischemic stroke.

Frontiers in neurology·2025

Same author

Challenges in the Early Diagnosis and Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Adults: Current Perspectives.

Therapeutics and clinical risk management·2024

Same author

Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.

The Cochrane database of systematic reviews·2024

Same author

Proximity extension assay-based discovery of biomarkers for disease activity in chronic inflammatory demyelinating polyneuropathy.

Journal of neurology, neurosurgery, and psychiatry·2023

Same author

Serum B-cell activating factor is not a potential biomarker for disease activity in chronic inflammatory demyelinating polyneuropathy.

Journal of neuroimmunology·2023